Literature DB >> 6999351

Immunotherapy of malignant melanoma.

W D Terry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6999351     DOI： 10.1056/NEJM198011133032010

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Current aspects of immunotherapy in cancer.

Authors: 
Journal:  Langenbecks Arch Chir       Date:  1981

2.  Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.

Authors:  R J Natuk; J A Byrne; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.

Authors:  J A Byrne; M Soloski; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.

Authors:  G Cianciolo; J Hunter; J Silva; J S Haskill; R Snyderman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.